BACK PRINT
Aricept

Once-A-Day Aricept® (donepezil HCI)

Home
Alzheimer's and Your Loved One
About Aricept
Managing a Loved One's Care
Dealing With Difficult Situations
Enjoying Time With Your Loved One
Caregiver Support
Concerned You May Have Alzheimer's?
Request More Information
Healthcare Professionals
Important Safety Information
Prescribing Information
Site Map
 
Enlarge Type

Privacy Policy

Privacy

Last updated February 2006

Scope

This notice provides highlights of the full Pfizer Inc privacy statement and applies to TRUSTe certified Pfizer Web sites. Visit the TRUSTe Web site to view a complete list of Pfizer Web sites with Validated Privacy Statements.

View the full Pfizer Privacy Statement.

View the full Eisai Privacy Statement.

Personal Information

  • Generally, you can access and browse our Web sites without disclosing any personally identifiable information.
  • If you request information, products or services from our sites, or ask us to resolve complaints or concerns, we may ask you to provide information such as your name, contact information and other identifying information necessary to fulfill a particular request.
  • We may also collect information a visitor voluntarily provides through responses to questionnaires, surveys, search functions and health assessment tools.
  • Eisai and Pfizer sites use cookies and other technologies to identify users as they move through our Web sites. Your Web browser can be set to allow you to control whether you will accept cookies, reject cookies, or to notify you each time a cookie is sent.

Additional Information from Pfizer

Additional Information from Eisai

How to Contact Us

With questions about this privacy statement or about Pfizer's handling of your information please contact our Privacy Officer.

or
Pfizer Inc
Privacy Officer
235 E 42 Street
Mail Stop 235/26/6
New York, NY 10017

or

Eisai Inc.
Privacy Inquiry
100 Tice Blvd.
Woodcliff Lake, New Jersey 07677

Pfizer Inc is a TRUSTe licensee. Contact Watchdog dispute resolution if a privacy issue is not properly addressed by us.

Uses

We use personal information you provide to fulfill your request for information, products or services as per your consent. We may seek your general consent to provide additional information, products or services. We give you notice of how your information will be used at the point of collection.

  • We may personalize our Web sites to provide you with a customized interactive experience, and we may target our marketing and health care messaging on those sites based on information we have about you.
  • We do not sell, rent or share your personal information with outside third parties. In order to provide services, we may provide information to other companies who work on our behalf. When we do so, we use our best efforts to assure that they agree in writing to abide by Eisai and Pfizer privacy policies.

Additional Information from Pfizer

Additional Information from Eisai

Your Rights and Choices

  • You can unsubscribe from communications you no longer wish to receive. We provide unsubscribe (opt-out) instructions in our communications.
  • You can also contact us at Privacy Officer or the postal address above if you want to update your personal information or change your marketing preferences.

Additional Information from Pfizer

Additional Information from Eisai

Important Information

  • We do not knowingly collect personally identifiable information from any person under the age of 13 without parental consent.
  • We have put in place appropriate physical, electronic, and managerial procedures to safeguard and prevent unauthorized access, maintain data security, and correctly use the information we collect online.

Important Safety Information

ARICEPT® (donepezil HCL tablets) is indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer's type.

ARICEPT is well tolerated but may not be for everyone. People at risk for stomach ulcers or who take certain other medicines should tell their doctors because serious stomach problems, such as bleeding, may get worse. Some people who take ARICEPT may experience fainting. Some people may have nausea, vomiting, diarrhea, bruising, or not sleep well. Some people may have muscle cramps or loss of appetite or may feel tired. In studies these were usually mild and temporary. For full prescribing information, please visit Prescribing Information.

 

This Web site contains information relating to various medical conditions and their treatment. Such information is provided for educational purposes only and is not meant to be a substitute for the advice of a physician or other health care professional. You should not use this information for diagnosing a health problem or disease. In order for you to make intelligent health care decisions, you should always consult with a physician or other health care provider for your, or your loved one's, personal medical needs.

All quotes included in this Web site represent the individual experience of some doctors, some patients, and their caregivers. Individual responses to Aricept treatment may vary. Actual identities have been changed to protect individual privacy.

This site is intended for residents of the United States only. The products discussed herein may have different product labeling in different countries.

ARICEPT® (donepezil HCl tablets) is a registered trademark of Eisai Co., Ltd.
Copyright © 2008 Eisai Inc. and Pfizer Inc. All rights reserved. AR280275L

Eisai   Pfizer   Legal Notices and Disclaimers  |  Privacy Policy  Reviewed by Trust·e Site Privacy Statement